Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injury
COVID-19 급성 폐 손상과 관련된 염증성 사이토카인에 대한 다양한 치료 세포 유형 감수성의 직접 비교
Research
[키워드] acute lung injury
acute respiratory distress
acute respiratory distress syndrome
Alter
Analysis
ARDS
ARDS patients
Bone marrow
Cell
Cell therapy
cell type
cell viability
cells
characterized
clinical evaluation
clinical trial
clinically
Combination
conditioned media
COVID-19
COVID-19 ARDS patient
cytokine
Cytokine storm
Cytokines
Cytometry
deleterious effect
determine
Direct
Disease progression
dose
doses
dysregulated immune response
evaluate the effect
excluded
expression
Extracellular
Extracellular vesicles
Flow
flow cytometry
greater
high risk
IL-6
immunomodulatory
implicated
Infection
Inflammatory cytokine
Inflammatory cytokines
inflammatory mediator
Inflammatory mediators
mediators
Mesenchymal stromal cells
Mild
Mortality
not altered
Novel coronavirus
paracrine
pathology
Patient
pro-inflammatory mediator
pro-inflammatory mediators
progression
proteomic
receptor
receptors
respiratory distress
Respiratory distress syndrome
Result
severe ARDS
severe COVID-19
stem cell
stem cells
stromal cells
supplementary material
survival
susceptibility
syndrome
the cell
therapeutic
therapeutic efficacy
therapy
Treatment
umbilical
Vesicle
viability
were assessed
widespread
with COVID-19
[DOI] 10.1186/s13287-021-02699-7 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s13287-021-02699-7 PMC 바로가기 [Article Type] Research